Trioxifene (LY-133314) is a selective estrogen receptor modulator (SERM) with competitive binding activity against estradiol for estrogen receptor alpha (ERalpha) and antagonistic activity against ERalpha-mediated gene expression. It has demonstrated anticancer effects in animal studies indicating that it may be useful for the treatment of breast cancer.
This page contains content from the copyrighted Wikipedia article "Trioxifene"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
